Preparation, characterization, and in vitro/vivo evaluation of polymer-assisting formulation of atorvastatin calcium based on solid dispersion technique

Desager, 1993, Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme: a reductase inhibitors, Clin Pharmacokinet, 31, 348, 10.2165/00003088-199631050-00003 Jahangiri, 2016, Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions, Eur J Pharm Sci, 82, 21, 10.1016/j.ejps.2015.11.007 Yin, 2009, Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium, Drug Deliv, 16, 30, 10.1080/10717540802481380 Shete, 2010, Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples, AAPS PharmSciTech, 11, 598, 10.1208/s12249-010-9419-7 Palanisamy, 2016, Atorvastatin ecyclodextrin systems: Physiochemical and biopharmaceutical evaluation, J Drug Deliv Sci Technol, 31, 41, 10.1016/j.jddst.2015.11.003 Choudhary, 2012, Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability, Acta Pharm Sci B, 2, 421, 10.1016/j.apsb.2012.05.002 Jinno, 2006, Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs, J Control Release, 111, 56, 10.1016/j.jconrel.2005.11.013 Li, 2017, The pharmacokinetics and anti-inflammatory effects of chelerythrinr solid dispersion in vivo, J Drug Deliv Sci Technol, 40, 51, 10.1016/j.jddst.2017.05.023 Sethia, 2004, Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods, Int J Pharm, 272, 1, 10.1016/j.ijpharm.2003.11.025 Leuner, 2000, Improving drug solubility for oral delivery using solid dispersions, Eur J Pharm Biopharm, 50, 47, 10.1016/S0939-6411(00)00076-X Jaywant, 2016, Development of amorphous dispersions of artemether with hydrophilic polymers via spray drying: physicochemical and in silico studies, Asian J Pharm Sci, 11, 385, 10.1016/j.ajps.2015.08.012 Pradhan, 2016, Preparation and characterization of spray-dried valsartan-loaded Eudragit® solid dispersion microparticles, Asian J Pharm Sci, 11, 744, 10.1016/j.ajps.2016.05.002 Serajuddin, 2007, Salt formation to improve drug solubility, Adv Drug Deliv Rev, 59, 603, 10.1016/j.addr.2007.05.010 Engel, 2000, Salt form selection and characterization of LY333531 mesylate monohydrate, Int J Pharm, 198, 239, 10.1016/S0378-5173(00)00350-1 Kumar, 2017, Atorvastatin calcium encapsulated eudragit nanoparticles with enhanced oral bioavailability, safety and efficacy profile, Pharm Dev Technol, 22, 156, 10.3109/10837450.2015.1108983 Sawicki, 2017, Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies, Drug Dev Ind Pharm, 43, 584, 10.1080/03639045.2016.1274901 Sawicki, 2016, Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxel, Int J Pharm, 511, 765, 10.1016/j.ijpharm.2016.07.068 Choi, 2017, Enhanced stability and solubility of pH-dependent drug, telmisartan achieved by solid dispersion, J Drug Deliv Sci Technol, 37, 194, 10.1016/j.jddst.2017.01.001 Chen, 2014, Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods, Int J Pharm, 473, 458, 10.1016/j.ijpharm.2014.07.043 Shuai, 2016, Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability, Eur J Drug Metab Pharmacokinet, 41, 413, 10.1007/s13318-015-0265-6 Jahangiri, 2015, Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions, Powder Technol., 286, 538, 10.1016/j.powtec.2015.08.047 Riehm, 2018, Poloxamer 188 decreases membrane toxicity of mutant SOD1 and ameliorates pathology observed in SOD1 mouse model for ALS, Neurobiol Dis, 115, 115, 10.1016/j.nbd.2018.03.014 Ban, 2017, Poloxamer-based thermoreversible gel for topical delivery of emodin: influence of P407 and P188 on solubility of emodin and its application in cellular activity screening, Molecules, 22, 246, 10.3390/molecules22020246 Ha, 2014, Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying technique, Chem Pharm Bull, 62, 545, 10.1248/cpb.c14-00030 Shamsuddin, 2016, Atorvastatin solid dispersion for bioavailability enhancement, J Adv Pharm Technol Res, 7, 22, 10.4103/2231-4040.169873 Hu, 2014, Investigation of solid dispersion of atorvastatin calcium inpolyethylene Glycol 6000 and polyvinylpyrrolidone, Trop J Pharm Res, 13, 835, 10.4314/tjpr.v13i6.2 Ahmed, 2016, PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-caprolactone nanoparticles, Int J Pharm, 504, 70, 10.1016/j.ijpharm.2016.03.045 Lu, 2017, Study on enhanced dissolution of azilsartan-loaded solid dispersion, prepared by combining wet milling and spray-drying technologies, AAPS PharmSciTech, 18, 473, 10.1208/s12249-016-0531-1 Ghanavati, 2017, Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier, Mater Sci Eng C Mater Biol Appl, 72, 501, 10.1016/j.msec.2016.11.042 Li, 2017, The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo, Asian J Pharm Sci, 12, 285, 10.1016/j.ajps.2016.08.006 Machado, 2014, Development and validation of a discriminative dissolution method for atorvastatin calcium tablets using in vivo data by LC and UV methods, AAPS PharmSciTech, 15, 189, 10.1208/s12249-013-0053-z Shingel, 2017, Solid dispersion of drugs in hyaluronan matrix: the role off the biopolymer in modulating drug activity in vivo, J Drug Deliv Sci Technol, 39, 140, 10.1016/j.jddst.2017.03.018 Drooge, 2004, Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions, J Control Release, 97, 441, 10.1016/j.jconrel.2004.03.018 Langham, 2012, Mechanistic insights into the dissolution of spray-dried amorphous solid dispersions, J Pharm Sci, 101, 2798, 10.1002/jps.23192 Prabhu, 2016, Dissolution enhancement of atorvastatin calcium by co-grinding technique, Drug Deliv Transl Res, 6, 380 Skorda, 2008, Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy, Talanta, 74, 1066, 10.1016/j.talanta.2007.07.030 Maurya, 2010, Microwave induced solubility enhancement of poorly water soluble atorvastatin calcium, J Pharm Pharmacol, 62, 1599, 10.1111/j.2042-7158.2010.01187.x Mahmoud, 2017, Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats, J Control Release, 254, 10, 10.1016/j.jconrel.2017.03.039 Sun, 2018, Effects of Danshen tablets on pharmacokinetics of atorvastatin calcium in rats and its potential mechanism, Pharm Biol, 56, 104, 10.1080/13880209.2018.1424209